Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents
This sustained usage could have lasting implications for brands, as additional data reveal shifts in daily habits
[1] [2] These medicines include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro), which is a dual GIP/GLP-1 receptor agonist
Localized itching alone is usually a minor inflammatory response, not an allergy
For personalized guidance on how semaglutide GLP-1 can help with appetite suppression and weight management, consult with Dr
Their effectiveness has revolutionized diabetes care, and brands like Ozempic and Mounjaro have become household names